Advertisement

transcript

This transcript was created using speech recognition software. While it has been reviewed by human transcribers, it may contain errors. Please review the episode audio before quoting from this transcript and email transcripts@nytimes.com with any

questions. name is Daniela Lamas, and I’m a pulmonary and critical care doctor at Brigham and Women’s Hospital in Boston.

[MUSIC PLAYING]

I often find myself drawn to stories that explore the nuance between surviving an illness and actually recovering, because there’s a lot of middle states that are created by medical interventions of people who have been through something catastrophic and lived, but aren’t yet OK. And so I’m really interested in the cost of that middle ground, not just the financial cost, but the emotional and psychological cost of survival.

Most recently, I’ve been looking into sickle cell disease and gene therapy as a cure for this disease. The FDA is actually expected to decide whether to approve a new gene therapy for sickle cell this week. Now, sickle cell itself is a disease where, over many years, in many ways, the medical establishment, I think, has really let down those who suffer from it. And this is our opportunity with this FDA approval and what comes after. This is our opportunity to do something different. This is our opportunity, I think, to do it right.

Yeah, I can hear you.

Yep, it’s rolling now.

In the course of my reporting, I was fortunate to meet many patients, these people who had undergone gene therapy trials. And the person that I really focused on ultimately is this fantastic, interesting, dynamic man named Lynndrick Holmes.

I’m from Mobile, Alabama, but now I live in Lockhart, Texas. I’m a father, I’m a poet, I’m a survivor, a fighter.

How would you describe back in Mobile, how would you describe your access to quality medical care?

It was accessible up until I transitioned from pediatric care to adult. When I got into adult care, it was like, welcome to the real world, brother. Do you know what your disease is? I don’t. Not my business. I’m not a sickle cell hematologist. Deal with it. Pain medicine. Are you an addict? And so it was just a whole new world, an awful world.

So sickle cell is a genetic disease that causes red blood cells to sickle, to change their shape. And so they clog blood vessels and block blood flow, and as a result, cause both excruciating pain and organ damage, and ultimately, an early death. Sickle cell affects about 100,000 people in the US, and they are predominantly Black. Patients often face a good degree of racism in getting treatment. And that is all along the line from access to care to access to people who actually know about sickle cell disease.

I come from a very black and white type of state. They judge you based on the kind of person they think you are, and that affects every aspect of your life. It affects how the teachers treat you. That affects how law enforcement treats you. That affects, of course, how doctors treat you.

So when it came to treatment, that was literally a life or death situation to me, because if I’m perceived to be a certain way, then they’re just going to whisk me away or just deal with me, like, get him his pain medicine so he can get out of my emergency room, instead of actually giving me the treatment that I deserve. So racism played a major part in not just trying to survive with sickle cell, but just trying to survive, period.

Lynndrick had sickle cell crises throughout his childhood. I mean, he talks about having spent first grade largely in the hospital, sort of watching children play through a window. And by the time that he was in his 20s and had lost possibility after possibility, he began to get fed up.

I was suicidal. I was pretty much done with the whole rigmarole of building a life, then losing that life. You get a job, you have a source of income, you get a place to live, and then you have a social life and all these kind of things.

And every time I would have a major sickle cell crisis and I’m out of work for an X amount of weeks, I lose my job, which means I can’t keep up with my cell phone bill, and I can’t keep up with my car note. I can’t keep up with my rent. I can’t keep up with none of this. And it was because I kept getting sick. So I kept going through that cycle, and I was just tired, especially if I was going to die anyway.

Lynndrick was desperate, and he had a memory of being a child and going to sickle cell clinic, and he has a memory of a nurse saying something about STEM cells and about their ability to, perhaps, one day treat this disease.

And so that memory provoked me to go to the library and google to try to see where they were because I figured, like, a lot of years have passed since then. They must have gotten further than they were when I was a kid.

Google actually took him to an NIH website, and he hadn’t actually heard of the NIH, the National Institutes of Health. But the NIH website ends.gov, and so he figured that this must be a legitimate website. And it took him to ongoing NIH trials of gene therapy and STEM cell transplant for sickle cell disease.

I was just reaching out for just general information. I was just like, please, just, I need to know what do I need to do to be a part of this.

And when you heard back from the people that you sent a message to at the NIH, kind of, how did you feel about the possibility of gene therapy when you first heard about it?

I first, I was skeptical because it felt like, I didn’t know. Like, there was a moment where I was like, this is a scam. And I was just like, well, it can’t be. So I just went ahead and moved on with it. I listened to them.

Lynndrick qualified for a trial of gene therapy, and here’s how that works. All of us have STEM cells in our bone marrow that create blood cells. Lynndrick’s make the misshapen sickled red blood cells that cause him all of his troubles. In gene therapy, Lynndrick’s bone marrow was removed from his body. And in a lab, technicians edit this single gene so that the STEM cells in his bone marrow make more healthy red blood cells, instead of the sickled ones. And then the genetically changed bone marrow is given back to him.

This is a brutal treatment, and Lynndrick signed up to go to the hospital and actually have intensive chemotherapy given to him to get rid of his entire existing bone marrow so that they would be able to give back this new gene-engineered version of his bone marrow that would make the good red blood cells. It speaks to the degree of desperation and how awful this disease is that people will undergo this treatment. I also talked to some people who felt like their pain, though disabling, was a pain that they knew, and it wasn’t a gamble that they were willing to undergo.

There is a range of the amount of time it will take to actually harvest enough bone marrow to make this treatment, but for Lynndrick, it actually took three years. And then Lynndrick underwent chemo, and then it was transplant day.

The day of, they came in with balloons and stuff. Like, they brought it in like it was my birthday. It was like, it’s your birthday today. You get new cells, man. It just dripped in through my IV, and the cells did their thing. When they got in my bloodstream, they went to where they was supposed to go.

What is your life overall like now, this many years after treatment?

So before treatment, I was in ROTC. And I was an ace when it came to the pushups and situps. But every time it got to that mile or the mile and a half, I couldn’t even do 0.25 miles without having sickle cell complications. Now I can stop when I want to stop. It’s awful. It sucks. Running is awful. Your feet hurt, your calves hurt. Everything burns. I can’t believe that I was asking God for this. That’s what I think to myself whenever I get to that moment. I’m like, when is the second win going to come, right? I don’t feel it. It hurts, but I can push through that and lean into that pain, knowing that the consequence won’t be sickle cell. You know what I mean?

Would you say you feel like your identity has changed post-treatment?

A lot. [LAUGHS]

Tell me about that.

Um —

.

So I feel like I got what I asked for. I was just like, hey, God, cure me of sickle cell. I’d rather have normal problems than these. And God was like, OK. Yep. Yep. You ain’t got sickle cell no more. How about them problems, though, bruh? So it’s like, I’m normal. I deal with normal stuff. I have an ex-wife. I got children, and I’m trying to meander my way through this thing called life. And I’m honestly enjoying every moment of it. I mean, some of it is beautiful. Some of it is awful. But at least I have autonomy through it. And I think that is the most essential thing to me.

It is incredibly exciting that this gene therapy will likely be available, but there are still looming questions about who pays for it. Lynndrick was part of a trial, so he didn’t have to worry about cost. If the treatment’s approved by the FDA, however, future patients will have to think about cost.

Insurers and Medicaid should definitely commit to covering this cost. For one, this might sound like an expensive treatment. And it is, but care for chronic disease over time can be even more expensive in terms of cost to the system as a whole, and of course, cost to the individual. Additionally, without covering this, we threaten to worsen health inequities by making this a therapy that is only accessible to people who have a particular type of private insurance that will offer it.

I came away believing that this treatment is really an opportunity for hope for a population that hasn’t had much, and also that this treatment is really only where it begins. The science is only where it begins. That dissemination, education, implementation, that’s going to make the difference between whether this is something that was amazing science, but never really made it to people in a meaningful way, or whether this truly shifts the course of what it means to have sickle cell.

Sitting where you are now, what are your hopes for people with sickle cell disease?

My hopes is that we can finally live — they ‘cause I guess I’m not necessarily a part of “we” no more. My hopes is that they can finally live with hope.

transcript

This transcript was created using speech recognition software. While it has been reviewed by human transcribers, it may contain errors. Please review the episode audio before quoting from this transcript and email transcripts@nytimes.com with any

questions. name is Daniela Lamas, and I’m a pulmonary and critical care doctor at Brigham and Women’s Hospital in Boston.

[MUSIC PLAYING]

I often find myself drawn to stories that explore the nuance between surviving an illness and actually recovering, because there’s a lot of middle states that are created by medical interventions of people who have been through something catastrophic and lived, but aren’t yet OK. And so I’m really interested in the cost of that middle ground, not just the financial cost, but the emotional and psychological cost of survival.

Most recently, I’ve been looking into sickle cell disease and gene therapy as a cure for this disease. The FDA is actually expected to decide whether to approve a new gene therapy for sickle cell this week. Now, sickle cell itself is a disease where, over many years, in many ways, the medical establishment, I think, has really let down those who suffer from it. And this is our opportunity with this FDA approval and what comes after. This is our opportunity to do something different. This is our opportunity, I think, to do it right.

Yeah, I can hear you.

Yep, it’s rolling now.

In the course of my reporting, I was fortunate to meet many patients, these people who had undergone gene therapy trials. And the person that I really focused on ultimately is this fantastic, interesting, dynamic man named Lynndrick Holmes.

I’m from Mobile, Alabama, but now I live in Lockhart, Texas. I’m a father, I’m a poet, I’m a survivor, a fighter.

How would you describe back in Mobile, how would you describe your access to quality medical care?

It was accessible up until I transitioned from pediatric care to adult. When I got into adult care, it was like, welcome to the real world, brother. Do you know what your disease is? I don’t. Not my business. I’m not a sickle cell hematologist. Deal with it. Pain medicine. Are you an addict? And so it was just a whole new world, an awful world.

So sickle cell is a genetic disease that causes red blood cells to sickle, to change their shape. And so they clog blood vessels and block blood flow, and as a result, cause both excruciating pain and organ damage, and ultimately, an early death. Sickle cell affects about 100,000 people in the US, and they are predominantly Black. Patients often face a good degree of racism in getting treatment. And that is all along the line from access to care to access to people who actually know about sickle cell disease.

I come from a very black and white type of state. They judge you based on the kind of person they think you are, and that affects every aspect of your life. It affects how the teachers treat you. That affects how law enforcement treats you. That affects, of course, how doctors treat you.

So when it came to treatment, that was literally a life or death situation to me, because if I’m perceived to be a certain way, then they’re just going to whisk me away or just deal with me, like, get him his pain medicine so he can get out of my emergency room, instead of actually giving me the treatment that I deserve. So racism played a major part in not just trying to survive with sickle cell, but just trying to survive, period.

Lynndrick had sickle cell crises throughout his childhood. I mean, he talks about having spent first grade largely in the hospital, sort of watching children play through a window. And by the time that he was in his 20s and had lost possibility after possibility, he began to get fed up.

I was suicidal. I was pretty much done with the whole rigmarole of building a life, then losing that life. You get a job, you have a source of income, you get a place to live, and then you have a social life and all these kind of things.

And every time I would have a major sickle cell crisis and I’m out of work for an X amount of weeks, I lose my job, which means I can’t keep up with my cell phone bill, and I can’t keep up with my car note. I can’t keep up with my rent. I can’t keep up with none of this. And it was because I kept getting sick. So I kept going through that cycle, and I was just tired, especially if I was going to die anyway.

Lynndrick was desperate, and he had a memory of being a child and going to sickle cell clinic, and he has a memory of a nurse saying something about STEM cells and about their ability to, perhaps, one day treat this disease.

And so that memory provoked me to go to the library and google to try to see where they were because I figured, like, a lot of years have passed since then. They must have gotten further than they were when I was a kid.

Google actually took him to an NIH website, and he hadn’t actually heard of the NIH, the National Institutes of Health. But the NIH website ends.gov, and so he figured that this must be a legitimate website. And it took him to ongoing NIH trials of gene therapy and STEM cell transplant for sickle cell disease.

I was just reaching out for just general information. I was just like, please, just, I need to know what do I need to do to be a part of this.

And when you heard back from the people that you sent a message to at the NIH, kind of, how did you feel about the possibility of gene therapy when you first heard about it?

I first, I was skeptical because it felt like, I didn’t know. Like, there was a moment where I was like, this is a scam. And I was just like, well, it can’t be. So I just went ahead and moved on with it. I listened to them.

Lynndrick qualified for a trial of gene therapy, and here’s how that works. All of us have STEM cells in our bone marrow that create blood cells. Lynndrick’s make the misshapen sickled red blood cells that cause him all of his troubles. In gene therapy, Lynndrick’s bone marrow was removed from his body. And in a lab, technicians edit this single gene so that the STEM cells in his bone marrow make more healthy red blood cells, instead of the sickled ones. And then the genetically changed bone marrow is given back to him.

This is a brutal treatment, and Lynndrick signed up to go to the hospital and actually have intensive chemotherapy given to him to get rid of his entire existing bone marrow so that they would be able to give back this new gene-engineered version of his bone marrow that would make the good red blood cells. It speaks to the degree of desperation and how awful this disease is that people will undergo this treatment. I also talked to some people who felt like their pain, though disabling, was a pain that they knew, and it wasn’t a gamble that they were willing to undergo.

There is a range of the amount of time it will take to actually harvest enough bone marrow to make this treatment, but for Lynndrick, it actually took three years. And then Lynndrick underwent chemo, and then it was transplant day.

The day of, they came in with balloons and stuff. Like, they brought it in like it was my birthday. It was like, it’s your birthday today. You get new cells, man. It just dripped in through my IV, and the cells did their thing. When they got in my bloodstream, they went to where they was supposed to go.

What is your life overall like now, this many years after treatment?

So before treatment, I was in ROTC. And I was an ace when it came to the pushups and situps. But every time it got to that mile or the mile and a half, I couldn’t even do 0.25 miles without having sickle cell complications. Now I can stop when I want to stop. It’s awful. It sucks. Running is awful. Your feet hurt, your calves hurt. Everything burns. I can’t believe that I was asking God for this. That’s what I think to myself whenever I get to that moment. I’m like, when is the second win going to come, right? I don’t feel it. It hurts, but I can push through that and lean into that pain, knowing that the consequence won’t be sickle cell. You know what I mean?

Would you say you feel like your identity has changed post-treatment?

A lot. [LAUGHS]

Tell me about that.

Um —

.

So I feel like I got what I asked for. I was just like, hey, God, cure me of sickle cell. I’d rather have normal problems than these. And God was like, OK. Yep. Yep. You ain’t got sickle cell no more. How about them problems, though, bruh? So it’s like, I’m normal. I deal with normal stuff. I have an ex-wife. I got children, and I’m trying to meander my way through this thing called life. And I’m honestly enjoying every moment of it. I mean, some of it is beautiful. Some of it is awful. But at least I have autonomy through it. And I think that is the most essential thing to me.

It is incredibly exciting that this gene therapy will likely be available, but there are still looming questions about who pays for it. Lynndrick was part of a trial, so he didn’t have to worry about cost. If the treatment’s approved by the FDA, however, future patients will have to think about cost.

Insurers and Medicaid should definitely commit to covering this cost. For one, this might sound like an expensive treatment. And it is, but care for chronic disease over time can be even more expensive in terms of cost to the system as a whole, and of course, cost to the individual. Additionally, without covering this, we threaten to worsen health inequities by making this a therapy that is only accessible to people who have a particular type of private insurance that will offer it.

I came away believing that this treatment is really an opportunity for hope for a population that hasn’t had much, and also that this treatment is really only where it begins. The science is only where it begins. That dissemination, education, implementation, that’s going to make the difference between whether this is something that was amazing science, but never really made it to people in a meaningful way, or whether this truly shifts the course of what it means to have sickle cell.

Sitting where you are now, what are your hopes for people with sickle cell disease?

My hopes is that we can finally live — they ‘cause I guess I’m not necessarily a part of “we” no more. My hopes is that they can finally live with hope.

By Daniela J. Lamas

Produced by Jillian Weinberger

This week, the F.D.A. is likely to approve the first gene therapy for sickle cell disease, a painful, life-shortening illness that affects around 100,000 Americans, most of them Black.

Dr. Daniela Lamas, a Times Opinion contributing writer, argues that for too long the American health care system has failed sickle cell patients. In her reporting, Dr. Lamas spoke with Lynndrick Holmes, a sickle cell patient who underwent a trial of gene therapy. In this audio essay, they explain how the new treatment works and why it’s an opportunity for the medical community to finally do right by patients who historically have been overlooked

The Times is committed to publishing a diversity of letters to the editor. We’d like to hear what you think about this or any of our articles. Here are some tips. And here’s our email: letters@nytimes.com.

Follow the New York Times Opinion section on Facebook, X (@NYTOpinion) and Instagram.

This episode of “The Opinions” was produced by Jillian Weinberger. It was edited by Kaari Pitkin, Alison Bruzek and Annie-Rose Strasser. Mixing by Sonia Herrero. Original music by Sonia Herrero, Pat McCusker and Carole Sabouraud. Fact-checking by Mary Marge Locker. Audience strategy by Kristina Samulewski and Shannon Busta.

Advertisement

QOSHE - A Brutal Disease, Gene Therapy and a Chance to Undo Past Wrongs - Jillian Weinberger
menu_open
Columnists Actual . Favourites . Archive
We use cookies to provide some features and experiences in QOSHE

More information  .  Close
Aa Aa Aa
- A +

A Brutal Disease, Gene Therapy and a Chance to Undo Past Wrongs

14 0
06.12.2023

Advertisement

transcript

This transcript was created using speech recognition software. While it has been reviewed by human transcribers, it may contain errors. Please review the episode audio before quoting from this transcript and email transcripts@nytimes.com with any

questions. name is Daniela Lamas, and I’m a pulmonary and critical care doctor at Brigham and Women’s Hospital in Boston.

[MUSIC PLAYING]

I often find myself drawn to stories that explore the nuance between surviving an illness and actually recovering, because there’s a lot of middle states that are created by medical interventions of people who have been through something catastrophic and lived, but aren’t yet OK. And so I’m really interested in the cost of that middle ground, not just the financial cost, but the emotional and psychological cost of survival.

Most recently, I’ve been looking into sickle cell disease and gene therapy as a cure for this disease. The FDA is actually expected to decide whether to approve a new gene therapy for sickle cell this week. Now, sickle cell itself is a disease where, over many years, in many ways, the medical establishment, I think, has really let down those who suffer from it. And this is our opportunity with this FDA approval and what comes after. This is our opportunity to do something different. This is our opportunity, I think, to do it right.

Yeah, I can hear you.

Yep, it’s rolling now.

In the course of my reporting, I was fortunate to meet many patients, these people who had undergone gene therapy trials. And the person that I really focused on ultimately is this fantastic, interesting, dynamic man named Lynndrick Holmes.

I’m from Mobile, Alabama, but now I live in Lockhart, Texas. I’m a father, I’m a poet, I’m a survivor, a fighter.

How would you describe back in Mobile, how would you describe your access to quality medical care?

It was accessible up until I transitioned from pediatric care to adult. When I got into adult care, it was like, welcome to the real world, brother. Do you know what your disease is? I don’t. Not my business. I’m not a sickle cell hematologist. Deal with it. Pain medicine. Are you an addict? And so it was just a whole new world, an awful world.

So sickle cell is a genetic disease that causes red blood cells to sickle, to change their shape. And so they clog blood vessels and block blood flow, and as a result, cause both excruciating pain and organ damage, and ultimately, an early death. Sickle cell affects about 100,000 people in the US, and they are predominantly Black. Patients often face a good degree of racism in getting treatment. And that is all along the line from access to care to access to people who actually know about sickle cell disease.

I come from a very black and white type of state. They judge you based on the kind of person they think you are, and that affects every aspect of your life. It affects how the teachers treat you. That affects how law enforcement treats you. That affects, of course, how doctors treat you.

So when it came to treatment, that was literally a life or death situation to me, because if I’m perceived to be a certain way, then they’re just going to whisk me away or just deal with me, like, get him his pain medicine so he can get out of my emergency room, instead of actually giving me the treatment that I deserve. So racism played a major part in not just trying to survive with sickle cell, but just trying to survive, period.

Lynndrick had sickle cell crises throughout his childhood. I mean, he talks about having spent first grade largely in the hospital, sort of watching children play through a window. And by the time that he was in his 20s and had lost possibility after possibility, he began to get fed up.

I was suicidal. I was pretty much done with the whole rigmarole of building a life, then losing that life. You get a job, you have a source of income, you get a place to live, and then you have a social life and all these kind of things.

And every time I would have a major sickle cell crisis and I’m out of work for an X amount of weeks, I lose my job, which means I can’t keep up with my cell phone bill, and I can’t keep up with my car note. I can’t keep up with my rent. I can’t keep up with none of this. And it was because I kept getting sick. So I kept going through that cycle, and I was just tired, especially if I was going to die anyway.

Lynndrick was desperate, and he had a memory of being a child and going to sickle cell clinic, and he has a memory of a nurse saying something about STEM cells and about their ability to, perhaps, one day treat this disease.

And so that memory provoked me to go to the library and google to try to see where they were because I figured, like, a lot of years have passed since then. They must have gotten further than they were when I was a kid.

Google actually took him to an NIH website, and he hadn’t actually heard of the NIH, the National Institutes of Health. But the NIH website ends.gov, and so he figured that this must be a legitimate website. And it took him to ongoing NIH trials of gene therapy and STEM cell transplant for sickle cell disease.

I was just reaching out for just general information. I was just like, please, just, I need to know what do I need to do to be a part of this.

And when you heard back from the people that you sent a message to at the NIH, kind of, how did you feel about the possibility of gene therapy when you first heard about it?

I first, I was skeptical because it........

© The New York Times


Get it on Google Play